Sarah is Counsel in the global antitrust group. She has extensive experience and technical expertise across a wide range of antitrust issues that arise on complex mergers and investigations. In her role, Sarah works with clients and lawyers across the global group to ensure the clients benefit from the group’s leading expertise in this rapidly developing area.
68
On 11 November 2020, the UK Government published its long-awaited National Security and Investment Bill (the Bill) in a significant departure from the 2018 White Paper (see our previous briefing). The Bill establishes a new screening regime for investments in a wide range of sensitive and (...)
144
Although many competition authorities are making considerable efforts to ensure “business as usual” during the COVID-19 crisis, the pandemic is inevitably having a material impact on merger control reviews around the globe. In addition to the obvious timing implications, deals are now being, and (...)
63
On 7 June 2018, the UK’s Competition Appeal Tribunal (CAT) partially set aside the Competition and Market Authority’s (CMA’s) decision fining Pfizer and Flynn nearly £90 million for charging unfairly high, or excessive, prices for phenytoin sodium capsules (an anti-epilepsy drug) in breach of EU (...)
41
In the same week as President Trump blocked Broadcom’s takeover of Qualcomm on national security grounds, the UK Government introduced draft legislation that will allow it to intervene in a wider range of investments in the military, dual-use, computing hardware and quantum technology sectors. (...)
45
On 15th September, the European Commission published the preliminary report on its e-commerce sector inquiry. The Commission has identified a number of business practices which it believes may restrict competition in online trade for consumer goods and digital content. It has warned of (...)
19 avenue Jean Aicard
75011 Paris, France
106 West 32nd Street, Suite 144
New York, NY, 10001, USA
563 Chiswick High Road
W4 3AY London, UK
